Kirk R. Schultz, MD

Dr. Kirk Schultz is a Professor at the University of British Columbia, BC Children’s Hospital, and the Child and Family research Institute (CFRI) who has published over 130 peer-reviewed articles in scientific journals. He is a Pediatric Hematologist Hematologist: (hee-muh-TOL-uh-jist) A doctor who specializes in treating blood diseases and disorders of blood producing organs. /Oncologist focused on new therapies and rejection in Blood and Marrow Transplantation (BMT) and immune therapy of blood cancers.Dr. Schultz was the recipient of the CIHR/Wyeth Clinical Research Clinical Research: A type of research that involves individual persons or a group of people. There are three types of clinical research. Patient-oriented research includes clinical trials which test how a drug, medical device, or treatment approach works in people. Epidemiology or behavioral studies look at the… Chair in Transplantation and is past chair of the Pediatric BMT Consortium the largest children’s BMT clinical trials clinical trials: Clinical research is at the heart of all medical advances, identifying new ways to prevent, detect or treat disease. If you have a bone marrow failure disease, you may want to consider taking part in a clinical trial, also called a research study. Understanding Clinical Trials Clinical… group in the world. He was recently appointed a fellowship in the Canadian Academy of health Sciences. Dr. Schultz heads the core for the newly formed Canadian Network Transplant Research Program (CNTRP). Dr. Schultz currently has ongoing research evaluating the underlying inherited causes of aplastic anemia aplastic anemia: (ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood cells, white blood cells, and platelets. The term aplastic is a Greek word meaning not to form. Anemia is a condition that happens when red blood cell count is low. Most… and myelodysplastic syndrome in children and adolescents and is focused on their long term outcomes.He is the director of the Childhood Cancer and Bloor Research (CCBR) group at the BC Children’s Hospital and CFRI.